Compare Enveric Biosciences Inc (ENVB) vs Yum! Brands, Inc. (YUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Yum! Brands, Inc. — how do they compare? Enveric Biosciences Inc trades at $1.39 (market cap $5.32M), while Yum! Brands, Inc. trades at $151.94 (market cap $42.05B). The key difference: Yum! Brands, Inc. is far larger — about 7904.1× Enveric Biosciences Inc's market cap, and Yum! Brands, Inc. pays a 1.97% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | YUM | |
|---|---|---|
Market Cap | $5.32M | $42.05B |
Sector | Health | Consumer Cyclical |
52-Week High | $17.40 | $168.16 |
52-Week Low | $1.28 | $138.21 |
Enterprise Value | $408.82K | $53.32B |
Dividend Yield | — | 1.97% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
YUM stock trades at $158.22, down 2.15% amid news of a health investigation at Taco Bell. The company recently sold Pizza Hut for $2.7 billion to focus on KFC and Taco Bell, authorizing a $4 billion buyback. Fundamentals show steady revenue growth to $8.21B in 2025 with a 20.48% net margin, though valuation ratios appear elevated with a P/E of 24.6. Technical indicators are mixed with a bearish overall signal but RSI near oversold levels at 26.
The strategic sale of Pizza Hut could streamline operations and boost capital returns, supporting the bullish $174.60 analyst target. However, near-term sentiment is pressured by the health investigation, while high debt levels and competitive pressures in quick-service restaurants present ongoing risks. The stock's current price sits below all analyst targets, suggesting potential upside if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Yum! Brands, Inc.
Yum Brands is a U.S.-based restaurant operator featuring a portfolio of four brands: KFC (26,930 global units), Pizza Hut (18,380 units), Taco Bell (7,790 units), and The Habit Burger (310 units) at year-end 2021. With $58 billion in 2021 systemwide sales, the firm is the second-largest restaurant company in the world, behind McDonald's ($112.5 billion) but ahead of Restaurant Brands International ($36 billion) and Starbucks ($25 billion). Yum is 98% franchised, with the largest franchisee, Yum China, created via a 2016 spinoff transaction (after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity). Yum is the newest evolution of Tricon Brands, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.
Read more on YUM →
